Optimized Antibody Drug Conjugate Development

Summary: One of the current challenges with existing ADCs is the difficulty in creating conjugates with a uniform drug to antibody ratio and consistent payload placement on the antibody, both aspects which are paramount in creating consistent and predictable therapies. The presentation will discuss the most recent data in the technology's development. This will include PK and toxicology data from primate studies illustrating how SMARTag™ technology allows for development of ADCs with favorable stability and safety profiles compared to alternative ADC technologies.

Download the Webinar